3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
8
Neoplasms
5
Lung Neoplasms
5
Head and Neck Neoplasms
5
Leukemia, Myeloid, Acute
4
Hematologic Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Pulmonary Disease, Chronic Obstructive
2
Neoplasm Metastasis
2
Lymphoma, Follicular
2
Leukemia
2
Colonic Neoplasms
2
COVID-19
2
Xerostomia
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Triple Negative Breast Neoplasms
1
Teratoma
1
Stroke
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Interventions
Radiotherapy
2
Radiation
2
Paclitaxel
2
Cisplatin
2
Carboplatin
2
Brachytherapy
2
Taxes
1
Standard of Care
1
Practice Guidelines as Topic
1
Platinum
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Endometrial Clear Cell Adenocarcinoma
×
Standard of Care
×
Clear all
NCT03422198
2025-12-12
SAVE
University of Utah
Phase 3
Recruiting
188 enrolled
15 charts